HEADER HYDROLASE 06-MAY-04 1T6D TITLE MIRAS PHASING OF THE AQUIFEX AEOLICUS PPX/GPPA PHOSPHATASE: CRYSTAL TITLE 2 STRUCTURE OF THE TYPE II VARIANT COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXOPOLYPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PPX/GPPA PHOSPHATASE; COMPND 5 EC: 3.6.1.11, 3.6.1.40; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 224324; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: PPX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ALPHA/BETA PROTEIN, ACTIN-LIKE FOLD, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR O.KRISTENSEN,M.LAURBERG,A.LILJAS,J.S.KASTRUP,M.GAJHEDE REVDAT 4 10-NOV-21 1T6D 1 REMARK SEQADV LINK REVDAT 3 13-JUL-11 1T6D 1 VERSN REVDAT 2 24-FEB-09 1T6D 1 VERSN REVDAT 1 03-AUG-04 1T6D 0 JRNL AUTH O.KRISTENSEN,M.LAURBERG,A.LILJAS,J.S.KASTRUP,M.GAJHEDE JRNL TITL STRUCTURAL CHARACTERIZATION OF THE STRINGENT RESPONSE JRNL TITL 2 RELATED EXOPOLYPHOSPHATASE/GUANOSINE PENTAPHOSPHATE JRNL TITL 3 PHOSPHOHYDROLASE PROTEIN FAMILY JRNL REF BIOCHEMISTRY V. 43 8894 2004 JRNL REFN ISSN 0006-2960 JRNL PMID 15248747 JRNL DOI 10.1021/BI049083C REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.KURODA,K.NOMURA,R.OHTOMO,J.KATO,T.IKEDA,N.TAKIGUCHI, REMARK 1 AUTH 2 H.OHTAKE,A.KORNBERG REMARK 1 TITL ROLE OF INORGANIC POLYPHOSPHATE IN PROMOTING RIBOSOMAL REMARK 1 TITL 2 PROTEIN DEGRADATION BY THE LON PROTEASE IN E. COLI REMARK 1 REF SCIENCE V. 293 705 2001 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 11474114 REMARK 1 DOI 10.1126/SCIENCE.1061315 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.D.KEASLING,L.BERTSCH,A.KORNBERG REMARK 1 TITL GUANOSINE PENTAPHOSPHATE PHOSPHOHYDROLASE OF ESCHERICHIA REMARK 1 TITL 2 COLI IS A LONG-CHAIN EXOPOLYPHOSPHATASE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 90 7029 1993 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 8394006 REMARK 1 DOI 10.1073/PNAS.90.15.7029 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.REIZER,A.REIZER,M.H.SAIER JR.,P.BORK,C.SANDER REMARK 1 TITL EXOPOLYPHOSPHATE PHOSPHATASE AND GUANOSINE PENTAPHOSPHATE REMARK 1 TITL 2 PHOSPHATASE BELONG TO THE SUGAR KINASE/ACTIN/HSP 70 REMARK 1 TITL 3 SUPERFAMILY REMARK 1 REF TRENDS BIOCHEM.SCI. V. 18 247 1993 REMARK 1 REFN ISSN 0968-0004 REMARK 1 PMID 8212131 REMARK 1 DOI 10.1016/0968-0004(93)90172-J REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 2055074.010 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 66398 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.206 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1348 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.28 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 10870 REMARK 3 BIN R VALUE (WORKING SET) : 0.2370 REMARK 3 BIN FREE R VALUE : 0.2950 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 239 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.019 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4850 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 10 REMARK 3 SOLVENT ATOMS : 334 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.27000 REMARK 3 B22 (A**2) : 4.41000 REMARK 3 B33 (A**2) : -1.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.100 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.710 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.550 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.480 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.250 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.380 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 46.24 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CSX.PARAM REMARK 3 PARAMETER FILE 5 : TRS.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CSX.TOP REMARK 3 TOPOLOGY FILE 5 : TRS.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANOMALOUS DATA WAS USED IN REFINEMENT. REMARK 4 REMARK 4 1T6D COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAY-04. REMARK 100 THE DEPOSITION ID IS D_1000022368. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-SEP-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : SAGITALLY FOCUSING GE(220) AND A REMARK 200 MULTILAYER REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 66436 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : 0.07600 REMARK 200 R SYM (I) : 0.07600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 23.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : 0.28700 REMARK 200 R SYM FOR SHELL (I) : 0.28700 REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: PARTIAL MODEL PRODUCED BY REMARK 200 MIRAS PHASING REMARK 200 SOFTWARE USED: SOLVE, SHARP, CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG4000, PEG400, TRIS, ACETIC ACID, REMARK 280 MAGNESIUM CHLORIDE, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.78250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL RELEVANT UNIT IS MONOMERIC. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 LEU A 3 REMARK 465 ASP A 4 REMARK 465 ASN A 5 REMARK 465 LYS A 6 REMARK 465 PRO A 7 REMARK 465 HIS A 311 REMARK 465 SER A 312 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 LEU B 3 REMARK 465 ASP B 4 REMARK 465 ASN B 5 REMARK 465 LYS B 6 REMARK 465 PRO B 7 REMARK 465 LYS B 308 REMARK 465 GLU B 309 REMARK 465 ASN B 310 REMARK 465 HIS B 311 REMARK 465 SER B 312 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 48 9.06 52.61 REMARK 500 LEU A 131 -31.03 -132.79 REMARK 500 ILE A 165 57.03 -110.36 REMARK 500 PRO A 225 -179.94 -65.13 REMARK 500 MSE B 9 127.48 87.82 REMARK 500 TYR B 19 -45.39 -131.05 REMARK 500 ILE B 28 79.02 -107.46 REMARK 500 ASP B 30 69.34 -152.80 REMARK 500 LEU B 37 141.44 -171.92 REMARK 500 LYS B 48 17.86 46.33 REMARK 500 GLU B 51 -66.17 -96.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1T6C RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN WILD TYPE AT RESOLUTION 1.53 A DBREF 1T6D A 1 312 UNP O67040 O67040_AQUAE 1 312 DBREF 1T6D B 1 312 UNP O67040 O67040_AQUAE 1 312 SEQADV 1T6D GLY A -2 UNP O67040 CLONING ARTIFACT SEQADV 1T6D SER A -1 UNP O67040 CLONING ARTIFACT SEQADV 1T6D HIS A 0 UNP O67040 CLONING ARTIFACT SEQADV 1T6D MSE A 9 UNP O67040 MET 9 MODIFIED RESIDUE SEQADV 1T6D MSE A 82 UNP O67040 VAL 82 ENGINEERED MUTATION SEQADV 1T6D MSE A 138 UNP O67040 CYS 138 ENGINEERED MUTATION SEQADV 1T6D CSX A 289 UNP O67040 CYS 289 MODIFIED RESIDUE SEQADV 1T6D MSE A 306 UNP O67040 VAL 306 ENGINEERED MUTATION SEQADV 1T6D GLY B -2 UNP O67040 CLONING ARTIFACT SEQADV 1T6D SER B -1 UNP O67040 CLONING ARTIFACT SEQADV 1T6D HIS B 0 UNP O67040 CLONING ARTIFACT SEQADV 1T6D MSE B 9 UNP O67040 MET 9 MODIFIED RESIDUE SEQADV 1T6D MSE B 82 UNP O67040 VAL 82 ENGINEERED MUTATION SEQADV 1T6D MSE B 138 UNP O67040 CYS 138 ENGINEERED MUTATION SEQADV 1T6D CSX B 289 UNP O67040 CYS 289 MODIFIED RESIDUE SEQADV 1T6D MSE B 306 UNP O67040 VAL 306 ENGINEERED MUTATION SEQRES 1 A 315 GLY SER HIS MET SER LEU ASP ASN LYS PRO ILE MSE ARG SEQRES 2 A 315 VAL ALA SER ILE ASP ILE GLY SER TYR SER VAL ARG LEU SEQRES 3 A 315 THR ILE ALA GLN ILE LYS ASP GLY LYS LEU SER ILE ILE SEQRES 4 A 315 LEU GLU ARG GLY ARG ILE THR SER LEU GLY THR LYS VAL SEQRES 5 A 315 LYS GLU THR GLY ARG LEU GLN GLU ASP ARG ILE GLU GLU SEQRES 6 A 315 THR ILE GLN VAL LEU LYS GLU TYR LYS LYS LEU ILE ASP SEQRES 7 A 315 GLU PHE LYS VAL GLU ARG MSE LYS ALA VAL ALA THR GLU SEQRES 8 A 315 ALA ILE ARG ARG ALA LYS ASN ALA GLU GLU PHE LEU GLU SEQRES 9 A 315 ARG VAL LYS ARG GLU VAL GLY LEU VAL VAL GLU VAL ILE SEQRES 10 A 315 THR PRO GLU GLN GLU GLY ARG TYR ALA TYR LEU ALA VAL SEQRES 11 A 315 ALA TYR SER LEU LYS PRO GLU GLY GLU VAL MSE VAL VAL SEQRES 12 A 315 ASP GLN GLY GLY GLY SER THR GLU TYR VAL PHE GLY LYS SEQRES 13 A 315 GLY TYR LYS VAL ARG GLU VAL ILE SER LEU PRO ILE GLY SEQRES 14 A 315 ILE VAL ASN LEU THR GLU THR PHE PHE LYS GLN ASP PRO SEQRES 15 A 315 PRO THR GLU GLU GLU VAL LYS ARG PHE PHE GLU PHE LEU SEQRES 16 A 315 GLU LYS GLU LEU SER LYS VAL LYS LYS PRO VAL ASP THR SEQRES 17 A 315 ILE VAL GLY LEU GLY GLY THR ILE THR THR LEU ALA ALA SEQRES 18 A 315 LEU GLU TYR ASN VAL TYR PRO TYR ASP PRO GLN LYS VAL SEQRES 19 A 315 HIS GLY LYS VAL LEU THR TYR GLY GLN ILE LYS LYS TRP SEQRES 20 A 315 PHE ASP THR PHE LYS GLU ILE PRO SER GLU GLU ARG SER SEQRES 21 A 315 LYS ARG PHE ARG GLN VAL GLU ASP ARG ARG ALA LYS VAL SEQRES 22 A 315 ILE LEU ALA GLY ILE GLY ILE PHE LEU LYS THR LEU GLU SEQRES 23 A 315 ILE PHE GLU LYS ASP CSX LEU ILE VAL SER ASP TRP GLY SEQRES 24 A 315 LEU ARG GLU GLY VAL LEU VAL SER GLU MSE LEU LYS GLU SEQRES 25 A 315 ASN HIS SER SEQRES 1 B 315 GLY SER HIS MET SER LEU ASP ASN LYS PRO ILE MSE ARG SEQRES 2 B 315 VAL ALA SER ILE ASP ILE GLY SER TYR SER VAL ARG LEU SEQRES 3 B 315 THR ILE ALA GLN ILE LYS ASP GLY LYS LEU SER ILE ILE SEQRES 4 B 315 LEU GLU ARG GLY ARG ILE THR SER LEU GLY THR LYS VAL SEQRES 5 B 315 LYS GLU THR GLY ARG LEU GLN GLU ASP ARG ILE GLU GLU SEQRES 6 B 315 THR ILE GLN VAL LEU LYS GLU TYR LYS LYS LEU ILE ASP SEQRES 7 B 315 GLU PHE LYS VAL GLU ARG MSE LYS ALA VAL ALA THR GLU SEQRES 8 B 315 ALA ILE ARG ARG ALA LYS ASN ALA GLU GLU PHE LEU GLU SEQRES 9 B 315 ARG VAL LYS ARG GLU VAL GLY LEU VAL VAL GLU VAL ILE SEQRES 10 B 315 THR PRO GLU GLN GLU GLY ARG TYR ALA TYR LEU ALA VAL SEQRES 11 B 315 ALA TYR SER LEU LYS PRO GLU GLY GLU VAL MSE VAL VAL SEQRES 12 B 315 ASP GLN GLY GLY GLY SER THR GLU TYR VAL PHE GLY LYS SEQRES 13 B 315 GLY TYR LYS VAL ARG GLU VAL ILE SER LEU PRO ILE GLY SEQRES 14 B 315 ILE VAL ASN LEU THR GLU THR PHE PHE LYS GLN ASP PRO SEQRES 15 B 315 PRO THR GLU GLU GLU VAL LYS ARG PHE PHE GLU PHE LEU SEQRES 16 B 315 GLU LYS GLU LEU SER LYS VAL LYS LYS PRO VAL ASP THR SEQRES 17 B 315 ILE VAL GLY LEU GLY GLY THR ILE THR THR LEU ALA ALA SEQRES 18 B 315 LEU GLU TYR ASN VAL TYR PRO TYR ASP PRO GLN LYS VAL SEQRES 19 B 315 HIS GLY LYS VAL LEU THR TYR GLY GLN ILE LYS LYS TRP SEQRES 20 B 315 PHE ASP THR PHE LYS GLU ILE PRO SER GLU GLU ARG SER SEQRES 21 B 315 LYS ARG PHE ARG GLN VAL GLU ASP ARG ARG ALA LYS VAL SEQRES 22 B 315 ILE LEU ALA GLY ILE GLY ILE PHE LEU LYS THR LEU GLU SEQRES 23 B 315 ILE PHE GLU LYS ASP CSX LEU ILE VAL SER ASP TRP GLY SEQRES 24 B 315 LEU ARG GLU GLY VAL LEU VAL SER GLU MSE LEU LYS GLU SEQRES 25 B 315 ASN HIS SER MODRES 1T6D MSE A 9 MET SELENOMETHIONINE MODRES 1T6D MSE A 82 MET SELENOMETHIONINE MODRES 1T6D MSE A 138 MET SELENOMETHIONINE MODRES 1T6D CSX A 289 CYS S-OXY CYSTEINE MODRES 1T6D MSE A 306 MET SELENOMETHIONINE MODRES 1T6D MSE B 9 MET SELENOMETHIONINE MODRES 1T6D MSE B 82 MET SELENOMETHIONINE MODRES 1T6D MSE B 138 MET SELENOMETHIONINE MODRES 1T6D CSX B 289 CYS S-OXY CYSTEINE MODRES 1T6D MSE B 306 MET SELENOMETHIONINE HET MSE A 9 8 HET MSE A 82 8 HET MSE A 138 8 HET CSX A 289 7 HET MSE A 306 8 HET MSE B 9 8 HET MSE B 82 8 HET MSE B 138 8 HET CSX B 289 7 HET MSE B 306 8 HET CL A 502 1 HET TRS A 601 8 HET CL B 501 1 HETNAM MSE SELENOMETHIONINE HETNAM CSX S-OXY CYSTEINE HETNAM CL CHLORIDE ION HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN TRS TRIS BUFFER FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 1 CSX 2(C3 H7 N O3 S) FORMUL 3 CL 2(CL 1-) FORMUL 4 TRS C4 H12 N O3 1+ FORMUL 6 HOH *334(H2 O) HELIX 1 1 LYS A 48 GLY A 53 1 6 HELIX 2 2 GLN A 56 PHE A 77 1 22 HELIX 3 3 GLU A 88 ALA A 93 5 6 HELIX 4 4 ASN A 95 GLY A 108 1 14 HELIX 5 5 THR A 115 LEU A 131 1 17 HELIX 6 6 GLY A 166 PHE A 175 1 10 HELIX 7 7 THR A 181 LYS A 198 1 18 HELIX 8 8 GLY A 210 TYR A 221 1 12 HELIX 9 9 ASP A 227 HIS A 232 1 6 HELIX 10 10 TYR A 238 GLU A 250 1 13 HELIX 11 11 PRO A 252 PHE A 260 1 9 HELIX 12 12 GLU A 264 LYS A 269 1 6 HELIX 13 13 VAL A 270 PHE A 285 1 16 HELIX 14 14 GLY A 296 ASN A 310 1 15 HELIX 15 15 LYS B 48 GLY B 53 1 6 HELIX 16 16 GLN B 56 PHE B 77 1 22 HELIX 17 17 ALA B 89 ALA B 93 5 5 HELIX 18 18 ASN B 95 GLY B 108 1 14 HELIX 19 19 THR B 115 LYS B 132 1 18 HELIX 20 20 GLY B 166 PHE B 175 1 10 HELIX 21 21 THR B 181 LYS B 198 1 18 HELIX 22 22 GLY B 210 TYR B 221 1 12 HELIX 23 23 ASP B 227 HIS B 232 1 6 HELIX 24 24 TYR B 238 GLU B 250 1 13 HELIX 25 25 PRO B 252 PHE B 260 1 9 HELIX 26 26 GLU B 264 ALA B 268 5 5 HELIX 27 27 LYS B 269 LYS B 269 5 1 HELIX 28 28 VAL B 270 PHE B 285 1 16 HELIX 29 29 GLY B 296 GLU B 305 1 10 SHEET 1 A 5 LEU A 33 ILE A 42 0 SHEET 2 A 5 SER A 20 ILE A 28 -1 N VAL A 21 O ARG A 41 SHEET 3 A 5 MSE A 9 ILE A 16 -1 N MSE A 9 O ILE A 28 SHEET 4 A 5 ARG A 81 ALA A 86 1 O VAL A 85 N ILE A 16 SHEET 5 A 5 VAL A 111 VAL A 113 1 O GLU A 112 N ALA A 84 SHEET 1 B 6 LYS A 156 LEU A 163 0 SHEET 2 B 6 SER A 146 LYS A 153 -1 N PHE A 151 O ARG A 158 SHEET 3 B 6 GLU A 136 GLY A 143 -1 N VAL A 137 O GLY A 152 SHEET 4 B 6 THR A 205 LEU A 209 1 O VAL A 207 N VAL A 140 SHEET 5 B 6 CSX A 289 VAL A 292 1 O ILE A 291 N ILE A 206 SHEET 6 B 6 VAL A 235 THR A 237 -1 N LEU A 236 O LEU A 290 SHEET 1 C 5 LEU B 33 ILE B 42 0 SHEET 2 C 5 SER B 20 ILE B 28 -1 N GLN B 27 O SER B 34 SHEET 3 C 5 ARG B 10 ILE B 16 -1 N VAL B 11 O ALA B 26 SHEET 4 C 5 ARG B 81 ALA B 86 1 O VAL B 85 N ILE B 14 SHEET 5 C 5 VAL B 111 VAL B 113 1 O GLU B 112 N ALA B 84 SHEET 1 D 6 LYS B 156 LEU B 163 0 SHEET 2 D 6 SER B 146 LYS B 153 -1 N PHE B 151 O ARG B 158 SHEET 3 D 6 VAL B 137 GLY B 143 -1 N VAL B 137 O GLY B 152 SHEET 4 D 6 THR B 205 LEU B 209 1 O VAL B 207 N VAL B 140 SHEET 5 D 6 CSX B 289 SER B 293 1 O ILE B 291 N ILE B 206 SHEET 6 D 6 VAL B 235 THR B 237 -1 N LEU B 236 O LEU B 290 LINK C ILE A 8 N MSE A 9 1555 1555 1.33 LINK C MSE A 9 N ARG A 10 1555 1555 1.33 LINK C ARG A 81 N MSE A 82 1555 1555 1.33 LINK C MSE A 82 N LYS A 83 1555 1555 1.33 LINK C VAL A 137 N MSE A 138 1555 1555 1.33 LINK C MSE A 138 N VAL A 139 1555 1555 1.33 LINK C ASP A 288 N CSX A 289 1555 1555 1.33 LINK C CSX A 289 N LEU A 290 1555 1555 1.33 LINK C GLU A 305 N MSE A 306 1555 1555 1.33 LINK C MSE A 306 N LEU A 307 1555 1555 1.33 LINK C ILE B 8 N MSE B 9 1555 1555 1.33 LINK C MSE B 9 N ARG B 10 1555 1555 1.33 LINK C ARG B 81 N MSE B 82 1555 1555 1.33 LINK C MSE B 82 N LYS B 83 1555 1555 1.33 LINK C VAL B 137 N MSE B 138 1555 1555 1.33 LINK C MSE B 138 N VAL B 139 1555 1555 1.33 LINK C ASP B 288 N CSX B 289 1555 1555 1.33 LINK C CSX B 289 N LEU B 290 1555 1555 1.33 LINK C GLU B 305 N MSE B 306 1555 1555 1.33 LINK C MSE B 306 N LEU B 307 1555 1555 1.33 CISPEP 1 ASP A 178 PRO A 179 0 0.05 CISPEP 2 TYR A 224 PRO A 225 0 -0.07 CISPEP 3 ASP B 178 PRO B 179 0 0.42 CISPEP 4 TYR B 224 PRO B 225 0 -0.16 SITE 1 AC1 6 GLN B 142 GLY B 143 GLY B 145 SER B 146 SITE 2 AC1 6 ILE B 167 HOH B 527 SITE 1 AC2 5 GLN A 142 GLY A 143 GLY A 145 GLY A 166 SITE 2 AC2 5 ILE A 167 SITE 1 AC3 7 GLU A 38 TYR A 226 PRO A 228 ASP A 294 SITE 2 AC3 7 ARG A 298 GLU A 299 HOH A 660 CRYST1 54.461 83.565 69.764 90.00 97.39 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018362 0.000000 0.002381 0.00000 SCALE2 0.000000 0.011967 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014454 0.00000